Marula Mining (LON: MARU) director Jason Brewer has increased his shareholding by 340,000 shares at 5.38p each. That takes his stake, held through Gathoni Muchai Investments to 9.13%. The share price increased 14.6% to 5.875p.
Ananda Developments (LON: ANA) says two of its potential medicines, MRX2 and MRX2T, will be used in National Institute for Health and Care Research and NHS co-funded phase IIIa epilepsy clinical trials involving up to 500 patients. This could support marketing authorisation applications if the trials are successful. The share price rose 3.17% to 0.325p.
EDX Medical Group (LON EDX) has raised £300,000 from a Saudi Arabian investor at 11p/share, which was a 22% premium to the market price. The share price improved 2.78% to 9.25p.
Corporate businesses developer Macaulay Capital (LON: MCAP) managing director David Horner has doubled his shareholding to 500,000 shares by buying 250,000 shares at 20p each. His family has a 24.9% stake. The share price edged up 2.7% to 19p.
FALLERS
Mendell Helium (LON: MDH) says Jill Overland is stepping down as a non-executive director. Additional directors will be appointed after the proposed acquisition of M3 Helium Corp. The share price dipped 12.3% to 2.85p.
Oscillate (LON: MUSH) has started hydrogen operations in Minnesota. A hydrogen soil-gas sensor has been bought and pre-field work started, which will provide data to enable further progress. Igraine has been diluted from 10.2% to 5.05% following the recent share issue. The share price fell 11.5% to 1.15p.
Electrification technology developer Equipmake (LON: EQIP) has raised £3m at 3p/share. Chief executive Ian Foley has subscribed for 6.67 million shares, although his stake will be diluted to 34.1%. The cash should last for six months and move the business towards cash breakeven. There was £2.48m in the bank at the end of May 2024. In the year to May 2024, the cash outflow from operations was £6.3m. The company estimates a requirement of £5.5m for working capital over the next 12 months. A potential licensing agreement could bring in £4.6m over a two-year period. Equipmake could reach cash breakeven in 2025-26. The focus is on higher margin work and bus repowering range will be rationalised. Costs are also being reduced, but it is investing in its commercial team. The share price dipped 8.33% to 2.75p.
Ormonde Mining (LON: ORM) investee company TRU Precious Metals Corp says backing from Eldorado Gold Corporation, which is earning an 80% stake in Golden Rose, has enabled a detailed review of the project. Initial targeting should be completed early next year. The share price declined 5.71% to 0.165p.
James and Alexandra Pace have a 5% stake in Shepherd Neame (LON: SHEP).The share price slipped 4.24% to 565p.